MedPath

Selective Laryngeal Reinnervation for Bilateral Vocal Fold Paralysis

Recruiting
Conditions
Bilateral Vocal Cord Paralysis
Registration Number
NCT03980275
Lead Sponsor
Weill Medical College of Cornell University
Brief Summary

This is a prospective observational study examining the treatment outcomes of selective laryngeal reinnervation procedures for patients with bilateral vocal fold paralysis.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Patients aged 18-70
  • Patients with bilateral vocal fold paralysis without any improvement for 6 months
Exclusion Criteria
  • Patients with neck or chest radiation
  • Patients with severe respiratory compromise
  • Patients with cricoarytenoid ankylosis
  • Patients with pacemakers
  • Patients who are pregnant
  • Patients with cochlear implant, or any nerve stimulator implants

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in breathing function is being assessed and measured by the Dyspnea Index (DI)Pre-surgery and then post-surgery at 1 week, 1 month, 3 months and every 3 months thereafter up to 18 months, then at 24 months

The DI is a standardized and validated tool to quantify patients' symptoms of upper airway dyspnea. It's a 10-item questionnaire. The lowest score is 0, which indicates that the patient is never experiencing dyspnea symptoms, and the highest is 40, which indicates that the patient is always experiencing dyspnea symptoms.

Change in breathing function is being assessed and measured by pulmonary function testingPre-surgery and then post-surgery at 1 week, 1 month, 3 months and every 3 months thereafter up to 18 months, then at 24 months

Pulmonary function testing will measure the total inspiratory and expiratory tidal volumes.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sean Parker Institute for the Voice

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath